# Enhanced Bioscaffold for Volumetric Muscle Loss

> **NCT04051242** · NA · TERMINATED · sponsor: **J. Peter Rubin, MD** · enrollment: 10 (actual)

## Conditions studied

- Muscle Loss

## Interventions

- **DEVICE:** XenMatrix™ AB Surgical Graft

## Key facts

- **NCT ID:** NCT04051242
- **Lead sponsor:** J. Peter Rubin, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-10
- **Primary completion:** 2024-01-24
- **Final completion:** 2024-01-24
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Did not complete planned enrollment.
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04051242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04051242, "Enhanced Bioscaffold for Volumetric Muscle Loss". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04051242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*